Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001085146-25-002803
Filing Date
2025-05-08
Accepted
2025-05-08 13:14:07
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 10106
2 jfa_20250211.pdf EX-99 21638
3 powerofattorney_20250211.pdf EX-24 107713
  Complete submission text file 0001085146-25-002803.txt   190256
Mailing Address 1 FIRST CANADIAN PLACE TORONTO A6 M5X 1A1
Business Address 1 FIRST CANADIAN PLACE TORONTO A6 M5X 1A1 000-000-0000
BANK OF MONTREAL /CAN/ (Filed by) CIK: 0000927971 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1031
Type: SCHEDULE 13G
SIC: 6029 Commercial Banks, NEC
(CF Office: 02 Finance)

Mailing Address 52 E 83RD ST. NEW YORK NY 10028
Business Address 52 E 83RD ST. NEW YORK NY 10028 (413) 204-2769
Translational Development Acquisition Corp. (Subject) CIK: 0001926599 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94817 | Film No.: 25925092
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)